{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T16:32:25Z","timestamp":1781109145118,"version":"3.54.1"},"reference-count":23,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000871","name":"Mayo Clinic","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001330","name":"Dr. Scholl Foundation","doi-asserted-by":"publisher","award":["UL1TR002377"],"award-info":[{"award-number":["UL1TR002377"]}],"id":[{"id":"10.13039\/100001330","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","heartrhythmjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heart Rhythm"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.hrthm.2021.09.016","type":"journal-article","created":{"date-parts":[[2021,9,16]],"date-time":"2021-09-16T02:52:37Z","timestamp":1631760757000},"page":"81-87","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Role of chronic continuous intravenous lidocaine in the clinical management of patients with malignant type 3 long QT syndrome"],"prefix":"10.1016","volume":"19","author":[{"given":"Sahej","family":"Bains","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adi","family":"Lador","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raquel","family":"Neves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Martijn","family":"Bos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John R.","family":"Giudicessi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryan C.","family":"Cannon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Ackerman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.hrthm.2021.09.016_bib1","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/s41572-020-0188-7","article-title":"Inherited cardiac arrhythmias","volume":"6","author":"Schwartz","year":"2020","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.hrthm.2021.09.016_bib2","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/j.jacc.2015.12.033","article-title":"Gene-specific therapy with mexiletine reduces arrhythmic events in patients with long QT syndrome type 3","volume":"67","author":"Mazzanti","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2021.09.016_bib3","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1001\/jama.292.11.1341","article-title":"Association of long QT syndrome loci and cardiac events among patients treated with \u03b2-blockers","volume":"292","author":"Priori","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.hrthm.2021.09.016_bib4","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1161\/CIRCULATIONAHA.116.021823","article-title":"Clinical aspects of type 3 long-QT syndrome: an international multicenter study","volume":"134","author":"Wilde","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2021.09.016_bib5","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1161\/01.CIR.103.1.89","article-title":"Genotype-phenotype correlation in the long-QT syndrome: gene-specific triggers for life-threatening arrhythmias","volume":"103","author":"Schwartz","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2021.09.016_bib6","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1007\/s00246-002-0169-5","article-title":"Congenital long QT syndrome and 2:1 atrioventricular block with a mutation of the SCN5A gene","volume":"24","author":"Miura","year":"2003","journal-title":"Pediatr Cardiol"},{"key":"10.1016\/j.hrthm.2021.09.016_bib7","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1161\/01.RES.0000069689.09869.A8","article-title":"Contribution of sodium channel mutations to bradycardia and sinus node dysfunction in LQT3 families","volume":"92","author":"Veldkamp","year":"2003","journal-title":"Circ Res"},{"key":"10.1016\/j.hrthm.2021.09.016_bib8","first-page":"302","article-title":"Cardiac standstill as a cause of death in long QT syndrome","volume":"23","author":"Medina","year":"1987","journal-title":"Isr J Med Sci"},{"key":"10.1016\/j.hrthm.2021.09.016_bib9","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1161\/CIRCULATIONAHA.110.950147","article-title":"Who are the long-QT syndrome patients who receive an implantable cardioverter-defibrillator and what happens to them? Data from the European Long-QT Syndrome Implantable Cardioverter-Defibrillator (LQTS ICD) Registry","volume":"122","author":"Schwartz","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2021.09.016_bib10","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1016\/j.hrthm.2010.08.023","article-title":"Implantable cardioverter defibrillator therapy for congenital long QT syndrome: a single-center experience","volume":"7","author":"Horner","year":"2010","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2021.09.016_bib11","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.tcm.2014.07.007","article-title":"MY APPROACH to treatment of the congenital long QT syndromes","volume":"25","author":"Ackerman","year":"2015","journal-title":"Trends Cardiovasc Med"},{"key":"10.1016\/j.hrthm.2021.09.016_bib12","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1161\/CIRCEP.113.000102","article-title":"Left cardiac sympathetic denervation in long QT syndrome: analysis of therapeutic nonresponders","volume":"6","author":"Bos","year":"2013","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.hrthm.2021.09.016_bib13","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1016\/j.jacep.2020.06.001","article-title":"Genotype predicts outcomes in fetuses and neonates with severe congenital long QT syndrome","volume":"6","author":"Moore","year":"2020","journal-title":"JACC Clin Electrophysiol"},{"key":"10.1016\/j.hrthm.2021.09.016_bib14","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1016\/j.hrthm.2017.04.023","article-title":"Cardiac transplantation in children and adolescents with long QT syndrome","volume":"14","author":"Kelle","year":"2017","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2021.09.016_bib15","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.jacc.2017.05.046","article-title":"Contemporary outcomes in patients with long QT syndrome","volume":"70","author":"Rohatgi","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2021.09.016_bib16","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1056\/NEJM199810013391404","article-title":"International Long-QT Syndrome Registry Research Group. Influence of the genotype on the clinical course of the long-QT syndrome","volume":"339","author":"Zareba","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hrthm.2021.09.016_bib17","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.1093\/eurheartj\/ehv316","volume":"36","author":"Priori","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hrthm.2021.09.016_bib18","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.bpa.2017.05.005","article-title":"Intravenous lidocaine","volume":"31","author":"Estebe","year":"2017","journal-title":"Best Pract Res Clin Anaesthesiol"},{"key":"10.1016\/j.hrthm.2021.09.016_bib19","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.cpcardiol.2013.08.001","article-title":"Genotype- and phenotype-guided management of congenital long QT syndrome","volume":"38","author":"Giudicessi","year":"2013","journal-title":"Curr Probl Cardiol"},{"key":"10.1016\/j.hrthm.2021.09.016_bib20","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1161\/CIRCULATIONAHA.107.707877","article-title":"Gating properties of SCN5A mutations and the response to mexiletine in long-QT syndrome type 3 patients","volume":"116","author":"Ruan","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2021.09.016_bib21","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1016\/j.hrthm.2020.05.019","article-title":"Purkinje system hyperexcitability and ventricular arrhythmia risk in type 3 long QT syndrome","volume":"17","author":"Barake","year":"2020","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2021.09.016_bib22","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.2165\/10898560-000000000-00000","article-title":"Impact of intravenous lidocaine infusion on postoperative analgesia and recovery from surgery: a systematic review of randomized controlled trials","volume":"70","author":"McCarthy","year":"2010","journal-title":"Drugs"},{"key":"10.1016\/j.hrthm.2021.09.016_bib23","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1053\/j.jvca.2011.03.008","article-title":"Population pharmacokinetics of lidocaine administered during and after cardiac surgery","volume":"25","author":"Hsu","year":"2011","journal-title":"J Cardiothorac Vasc Anesth"}],"container-title":["Heart Rhythm"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1547527121021263?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1547527121021263?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T06:55:28Z","timestamp":1761548128000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1547527121021263"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["S1547527121021263"],"URL":"https:\/\/doi.org\/10.1016\/j.hrthm.2021.09.016","relation":{},"ISSN":["1547-5271"],"issn-type":[{"value":"1547-5271","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Role of chronic continuous intravenous lidocaine in the clinical management of patients with malignant type 3 long QT syndrome","name":"articletitle","label":"Article Title"},{"value":"Heart Rhythm","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hrthm.2021.09.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Heart Rhythm Society. All rights reserved.","name":"copyright","label":"Copyright"}]}}